Impact of Verticalization Therapy in a Patient With Acute Respiratory Distress Syndrome and a Body Mass Index Greater Than 40: A Case Report

Author(s): Nakita N. Johns, MS, APRN, AGCNS-BC, ACCNS-AG, CCRN

Contact Hours 1.00

CERP A 1.00

Expires Mar 30, 2029

Topics: MultiSystem, Pulmonary

Fees
Member: Free
NonMember: $10.00

Added to Collection

Activity Summary

Required reading for all learners: Implicit Bias impacts patient outcomes

Obesity increases the risk of severe acute respiratory distress syndrome, prolonging mechanical ventilation duration and intensive care unit stays. Factors affected by obesity include diaphragm displacement and reduced lung volume. This case report discusses nursing care for a patient who received verticalization therapy, resulting in improved lung volume distribution and oxygenation Patient data, including vital signs, radiography results, and laboratory results, were collected as part of a retrospective review. The CARE (Case Report)11 guidelines were followed to report the case details. The aims of this article are to (1) raise awareness that verticalization therapy can be an alternative to prone positioning in treating patients with severe ARDS and obesity and (2) provide implications for nurse-led interventions when caring for patients with ARDS who have a larger body habitus.

Objectives

  • Describe the clinical course of a patient with obesity and severe ARDS requiring prolonged mechanical ventilation.
  • Examine nurse-led verticalization therapy as an intervention for refractory hypoxemia in mechanically ventilated patients.
  • Evaluate the impact of verticalization therapy on lung volume distribution and oxygenation in a critically ill patient.

Continuing Education Disclosure Statement

Criteria for Awarding Contact Hours

Learners must complete the entire activity and the associated evaluation AND read Implicit Bias impacts patient outcomes. No partial credit will be awarded.

Accreditation

American Association of Critical-Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Provider approved by the California Board of Registered Nursing, Provider number CEP 1036, for {contactHours} contact hours.

Disclosures

The Nurse Planner has determined that no individuals with the ability to control content of this activity have relevant relationships with ineligible companies.

Activities with pharmacotherapeutic credit are to assist the APRN in fulfilling their education requirements for licensure and certification renewals.

Refund Policy

Continuing Education Activities are nonrefundable.